61 the First-in-class Peroxiredoxin 3 (PRX3) Inhibitor RSO-021 Modulates the Mesenchymal and Immune Phenotype in MesotheliomaBrian Cunniff,Terri Messier,Victoria Gibson,David Seward,Essa Baitei,Peter Wells Jordan,Charlotte Poile,Joanna Dzialo,Aleksandra Bzura,Kudzayi Kutywayo,Apostolos Nakas,George Naumov,Dean FennellLung Cancer（2024）引用 0|浏览28AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
